Company Search:
Advanced Search
Sponsored Links
Arch Biopartners Inc Company Snapshot
Arch Biopartners Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Arch Biopartners Inc with three other companies in this sector in Canada: Promis Neurosciences Inc (2015 sales of 19,935.00 Canadian Dollars [US$15,056.71 ] of which 100% was Research and Develo), Pacgen Life Science Corporation (59,552.00 Canadian Dollars [US$44,979.03 ] ), and Novoheart Holdings Inc (11,876.00 Canadian Dollars [US$8,969.82 ] ).

Sales Analysis.
  Stock Performance Chart for Arch Biopartners Inc
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): .98
(Figures in Canadian Dollars)
1 Week 0.0%   13 Weeks -2.0%  
4 Weeks -7.5%   52 Weeks -31.0%  
Arch Biopartners Inc Key Data:
  Ticker: ARCH Country: Canada
  Exchanges: VEN Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 37,641
(Year Ending Jan 2016).
Employees: N/A
  Currency: Canadian Dollars Market Cap: 57,538,056
  Fiscal Yr Ends: September Shares Outstanding: 58,712,302
  Share Type: Closely Held Shares: 23,916,500
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.